To determine the association between both erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) and osteomyelitis recurrence. Methods. Records of 81 males and 27 females aged 10 to 87 (median, 54) years who underwent antibiotic/ surgical treatment for primary (n=68) or recurrent (n=40) osteomyelitis that was related (n=26) or unrelated (n=82) to a prosthesis were reviewed. Of the 40 cases of osteomyelitis recurrence followed up for a median of 23.4 (range, 0.6-74.0) months, 7 and 33 were related and unrelated to a prosthesis, respectively. The cutoff points of lowest ESR and CRP for osteomyelitis recurrence were calculated. Risk factors for osteomyelitis recurrence were determined. Results. Osteomyelitis recurrence was associated with diabetes mellitus, ischaemic heart disease, nonhealing wound, infection in the lower limb, and infection with methicillin-resistant Staphylococcus Use of erythrocyte sedimentation rate and C-reactive protein to predict osteomyelitis recurrence Journal of Orthopaedic Surgery 2016;24(1):77-83 aureus. The cutoff points of CRP ≥5 mg/l and ESR ≥20 mm/h were used for osteomyelitis recurrence. Risk factors for osteomyelitis recurrence were ESR ≥20 mm/h, infection with methicillin-resistant S aureus, and infection in the lower limb. Conclusion. ESR was more sensitive, specific, and independently associated with osteomyelitis recurrence and should be used to guide the duration of antibiotic treatment.
and is used for diagnosis of septic arthritis, acute rheumatic fever, and acute osteomyelitis. 6 The sensitivity and specificity of ESR and CRP alone or in combination for diagnosis of osteomyelitis is generally over 90%, especially when combined with white blood cell counts. [6] [7] [8] [9] The decision to stop antibiotic therapy for osteomyelitis is based on the resolution of overlying 
Materials and Methods
This study was approved by the National Healthcare Group Domain Specific Review Board. Records of 81 males and 27 females aged 10 to 87 (median, 54) years who underwent antibiotic/surgical treatment for primary (n=68) or recurrent (n=40) osteomyelitis that was related (n=26) or unrelated (n=82) to a prosthesis between January 2005 and January 2012 were reviewed. Of the 40 cases of osteomyelitis recurrence followed up for a median of 23.4 (range, 0.6-74.0) months, 7 and 33 were related and unrelated to a prosthesis, respectively. The diagnosis of osteomyelitis was made when the patients presented signs and symptoms of bone and/or joint infection of <2 weeks, and at least one of the following: (1) positive blood or tissue culture, (2) typical radiological findings (deep softtissue swelling, periosteal reaction, and/or bony destruction), and (3) surgical finding of pus in bone and/or joint. 10 Osteomyelitis recurrence was defined as re-admission for antibiotic/surgical treatment for osteomyelitis of the same site as the index admission. This was differentiated from persistent osteomyelitis in which antibiotics were continued and had not been stopped. Patients with fewer than 2 CRP and ESR readings were excluded.
The date of initial presentation of osteomyelitis was defined as time 0, whereas the end of followup was defined as the date of the last attendance or the date of re-admission (for recurrence). Patient age, gender, comorbidities, symptoms, site of osteomyelitis, microbiological results, and treatment options were recorded for analysis.
The cutoff points for osteomyelitis recurrence were determined separately for the lowest ESR and CRP using the area under the curve (AUC) in the receiver operating characteristic analysis. Risk factors for osteomyelitis recurrence were determined using the multivariable Cox regression analysis. Variables were found not to violate the proportional hazards assumption. All tests were 2-sided. A p value of <0.05 was considered statistically significant. Table 1 ].
results

In
The cutoff points that had high sensitivity and specificity were CRP 5, 6, 7, 8, and 9 mg/l and ESR ≥20, 25, and 30 mm/h ( Table 2 ). For overall osteomyelitis recurrence, the cutoff points of CRP ≥5 mg/l (sensitivity=62.5%, specificity=58.8%) and ESR ≥20 mm/h (sensitivity 85.0%, specificity 52.9%) were used because their sensitivity was highest. For prosthesis-related osteomyelitis recurrence, the cutoff points of CRP ≥5 mg/l (AUC=0.820, sensitivity=71.4%, specificity=84.2%) and ESR ≥20 mm/h (AUC=0.782, sensitivity=85.7%, specificity=73.7%) were used. For prosthesis-unrelated osteomyelitis recurrence, the cutoff points of CRP ≥8 mg/l (AUC=0.603, In multivariable Cox regression analysis, risk factors for overall osteomyelitis recurrence were ESR ≥20 mm/h (adjusted HR=4.17, 95% CI=1.73-10.0, p=0.001), infection with methicillin-resistant S aureus (adjusted HR=2.64, 95% CI=1.31-5.33, p=0.007), and infection in the lower limb (adjusted HR=2.44, 95% CI=1.12-5.34, p=0.025) [ Table 3 ]. Risk factors for prosthesis-related osteomyelitis were CRP ≥5 mg/l (adjusted HR=10.7, 95% CI=1.67-68.6, p=0.012) and infection with gram-positive microorganisms other than S aureus (adjusted HR=9.09, 95% CI=1.39-59.4, p=0.021). Risk factors for prosthesis-unrelated osteomyelitis were ESR ≥25 mm/h (adjusted HR=3.89, 95% CI=1.60-9.47, p=0.003) and infection with methicillin-resistant S aureus (adjusted HR=3.46, 95% CI=1.63-7.34, p=0.001).
discussion
Inflammatory markers have been used to monitor treatment progress. In a study investigating the efficacy of inflammatory markers (CRP, ESR, white blood cell counts, and procalcitonin) in diagnosis and monitoring patients with foot osteomyelitis, only ESR remained elevated in the presence of persistent osteomyelitis at one week post-treatment until 3 months. 9 Failure of ESR to normalise suggested a need for re-evaluation and may be associated with recurrence despite initial clinical resolution. 11 In a study of 16 patients with contiguous pedal osteomyelitis, failure of ESR to decline predicted treatment failure. 12 ESR >55 mm/h and CRP >27.5 mg/l at 4 weeks after antibiotic treatment was associated with a higher rate of treatment failure (defined as disease progression and recurrence) (odds ratio [OR]=5.2, 95% CI=1.00-26.6, p=0.04) in pyogenic vertebral osteomyelitis. 13 In a study involving 122 patients with diabetic foot osteomyelitis, stagnating trajectories of CRP and ESR were reported to be associated with recurrence and readmission over a follow-up period of one year. 14 Bone and joint infection with methicillin-resistant S aureus is reported to be associated with failure of initial prescription of outpatient parenteral antibiotic therapy (OR=3.3, 95% CI=1.2-9.5, p=0.03) and failure of initial therapy defined as recurrence or death after a median of 60 weeks (HR=2.2, 95% CI=1.1-3.3, p=0.009). 15 Prosthesis-related osteomyelitis is difficult to treat, owing to adherence of bacteria to biomaterials and tissues within biofilms. 16 ESR and CRP are effective in determining the presence of peri-prosthetic infection; using both can reduce the chance of false-negative results. [17] [18] [19] [20] Nonetheless, recurrence may occur years later. 21 There were limitations to the study. The study was retrospective, and 25 patients were excluded because of inadequate readings of CRP and ESR. Patient selection may have been biased because only patients in the inpatient setting were included. The number of patients with prosthesis-related osteomyelitis was insufficient for further analysis. The distinction between persistent and recurrent osteomyelitis may not have been absolute; some subclinical persistent osteomyelitis cases may have been counted as recurrent osteomyelitis. Owing to the retrospective nature of the study, patients were not clinically examined to confirm the resolution of the osteomyelitis.
conclusion
ESR was more sensitive, specific, and independently associated with osteomyelitis recurrence and should be used to guide the duration of antibiotic treatment.
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